Studying Health Outcomes After Treatment in Patients With Retinoblastoma (NCT03932786)
Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)
🩺 Plain-English Summary (8th-Grade Level)
This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
Who can join: Review the eligibility criteria below.
Location: Lurie Children's Hospital — Chicago, Illinois
🧪 Interventions in This Study
- Biospecimen collection (PROCEDURE)
- Vision assessment (OTHER)
- Questionnaire administration (OTHER)
- Quality of life assessment (OTHER)
- Laboratory Biomarker Analysis (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- Lurie Children's Hospital — Chicago, Illinois
- University of Illinois, Chicago — Chicago, Illinois
- University of Minnesoa — Minneapolis, Minnesota
- Washington School of Medicine at St. Louis — St Louis, Missouri
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee
- MD Anderson Cancer Center — Houston, Texas
- Texas Childeren's Hospital — Houston, Texas
- Children's Hospital of Wisconsin — Milwaukee, Wisconsin
- The Hosptial for Sick Children — Toronto,
📞 Contact the Study Coordinator
Phone: (800) 811-8480
Email: cip@vanderbilt.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Retinoblastoma
- Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma — Memphis, Tennessee
- Retinoblastoma Patient Clinical Database and Tissue Repository — Phoenix, Arizona
- Retinoblastoma Phase II Expanded Access Clinical Trial — New York, New York
- Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life — New York, New York
Explore by condition: All Retinoblastoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.